GRANISETRON HCL (GRANISETRON HCL)
- Prevention of chemotherapy-induced nausea and vomiting
- Post-operative nausea and vomiting
- Prevention of post-operative nausea and vomiting
- Granisetron Iv
- Granisetron Intravenous Solution
- Granisetron Hcl Intravenous Solution
- Granisetron (pf) Iv
- Granisetron (pf) Intravenous Solution
- By Indication
1 mg/mL (1 mL) intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL (1 mL) intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL (1 mL) intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL (1 mL) intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
100 mcg/mL (0.1 mg/mL) intravenous solution
- Infuse 10 mcg/kg over 30 second(s) by intravenous route undiluted once daily 30 minutes before chemotherapy
granisetron (PF) 1 mg/mL (1 mL) intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
granisetron (PF) 100 mcg/mL (0.1 mg/mL) intravenous solution
- Infuse 10 mcg/kg over 30 second(s) by intravenous route undiluted once daily 30 minutes before chemotherapy
Cancer chemotherapy-induced nausea and vomiting
- Infuse 10 mcg/kg by intravenous route once
Prevention of chemotherapy-induced nausea and vomiting
- Infuse 10 mcg/kg over 30 second(s) by intravenous route undiluted once daily 30 minutes before chemotherapy
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
Prevention of radiation-induced nausea and vomiting
- Infuse 10 mcg/kg over 30 second(s) by intravenous route undiluted once daily 30 minutes before chemotherapy
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
- apomorphine
- Apokyn
Contraindicated
- ziprasidone mesylate
- ziprasidone HCl
- toremifene
- thioridazine
- pimozide
- Pacerone
- Orap
- Norpace Cr
- Norpace
- Nexterone
- Multaq
- Geodon
- Fareston
- droperidol
- dronedarone
- disopyramide
- Cordarone
- Coartem
- artemether-lumefantrine
- amiodarone in dextrose,iso-osm
- amiodarone
Severe
Moderate
- Zuplenz
- Zofran Odt
- Zofran
- Zelboraf
- Xenazine
- Xalkori
- Votrient
- Vibativ
- Versacloz
- vemurafenib
- vandetanib
- Uroxatral
- Ultram Er
- Ultram
- Ultracet
- Tykerb
- Trisenox
- tramadol-glucosamine
- tramadol-acetaminophen
- tramadol
- Tikosyn
- tetrabenazine
- telavancin
- Tasigna
- Synapryn
- Sprycel
- Sotalol Af
- sotalol
- Sorine
- sorafenib
- Sirturo
- Signifor
- Seroquel Xr
- Seroquel
- saquinavir mesylate
- Rythmol
- romidepsin
- rilpivirine
- quinine sulfate
- quetiapine
- Qualaquin
- propafenone
- Potiga
- posaconazole
- pazopanib
- pasireotide
- paliperidone palmitate
- paliperidone
- ondansetron HCl (PF)
- ondansetron HCl
- ondansetron
- Noxafil
- Noroxin
- norfloxacin
- nilotinib
- Nexavar
- moxifloxacin in NaCl (iso-osm)
- moxifloxacin
- Methadose
- Methadone Intensol
- methadone
- lopinavir-ritonavir
- Lexapro
- levofloxacin in D5W
- levofloxacin
- Levaquin In 5 % Dextrose
- Levaquin
- lapatinib
- Kaletra
- Istodax
- Invirase
- Invega Sustenna
- Invega
- haloperidol lactate
- haloperidol decanoate
- haloperidol
- Haldol Decanoate
- Haldol
- Halaven
- gadofosveset trisodium
- Fazaclo
- ezogabine
- escitalopram oxalate
- eribulin
- emtricitab-rilpivirine-tenofov
- Edurant
- Dolophine
- dolasetron
- dofetilide
- Diskets
- dasatinib
- crizotinib
- Conzip
- Complera
- Clozaril
- clozapine
- citalopram
- ciprofloxacin in D5W
- ciprofloxacin (mixture)
- ciprofloxacin
- Cipro Xr
- Cipro In D5W
- Cipro
- Celexa
- Caprelsa
- Betapace Af
- Betapace
- bedaquiline
- Avelox In Nacl (iso-osmotic)
- Avelox Abc Pack
- Avelox
- arsenic trioxide
- Anzemet
- alfuzosin
- Ablavar
- None
Contraindicated
- Congenital long QT syndrome
- Doxorubicin-induced cardiomyopathy
- Hypokalemia
- Hypomagnesemia
- Neuroleptic malignant syndrome
- Prolonged QT interval
- Serotonin syndrome
Severe
Moderate
- Cardiac arrhythmia
GRANISETRON HCL (GRANISETRON HCL)
- Prevention of chemotherapy-induced nausea and vomiting
- Post-operative nausea and vomiting
- Prevention of post-operative nausea and vomiting
- None
- Acute abdominal pain
- Constipation
- Fatigue
More Frequent
Severe
Less Severe
- Fever
- Prolonged QT interval
- Abnormal hepatic function tests
- Agitation
- Diarrhea
- Dizziness
- Drowsy
- Dysgeusia
- Dyspepsia
- General weakness
- Headache disorder
- Hypertension
- Hypotension
- Insomnia
- Symptoms of anxiety
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Atrial fibrillation
- Bradycardia
- Cardiac arrhythmia
- Chest pain
- Dyspnea
- Hypersensitivity drug reaction
- Pruritus of skin
- Sick sinus syndrome
- Skin rash
- Syncope
- Urticaria
Less Severe
- Palpitations
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Granisetron (Inj)
Safety and efficacy not established, not studied age <2 years.
No safety and efficacy for use in post-op nausea and vomiting.
- 1 Day – 2 Years
- Safety and efficacy not established, not studied age <2 years.
- No safety and efficacy for use in post-op nausea and vomiting.
- 2 Years – 18 Years
- Safety and efficacy not established, not studied age <2 years.
- No safety and efficacy for use in post-op nausea and vomiting.
Granisetron
- Severity Level:
2
- Additional Notes: Insuff human data; animal data sug no known dev tox
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Granisetron
Insufficient data available.
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Post-operative nausea and vomiting | |
K91.0 | Vomiting following gastrointestinal surgery |
R11.2 | Nausea with vomiting, unspecified |
0-9 | A-Z |
---|---|
K91.0 | Vomiting following gastrointestinal surgery |
R11.2 | Nausea with vomiting, unspecified |